Company Valuation: An Phat Bioplastics

Data adjusted to current consolidation scope
Fiscal Period: December 2025 2026 2027
Market Cap 1 3,102,693 2,823,135 -
Change - -9.01% -
Enterprise Value (EV) 3,102,693 2,823,135 2,823,135
Change - -9.01% 0%
P/E - - -
PBR - - -
PEG - - -
Capitalization / Revenue 0.29x 0.31x 0.28x
EV / Revenue 0x 0.31x 0.28x
EV / EBITDA - - -
EV / EBIT - 7.41x 5.66x
EV / FCF - - -
FCF Yield - - -
Dividend per Share 2 - - -
Rate of return - - -
EPS 2 - - -
Distribution rate - - -
Net sales 1 10,728,147 9,170,000 10,110,000
EBITDA - - -
EBIT 1 - 381,000 499,000
Net income 372,913 - -
Net Debt - - -
Reference price 2 7,880.00 7,170.00 7,170.00
Nbr of stocks (in thousands) 393,743 393,743 -
Announcement Date 1/28/26 - -
1VND in Million2
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 113M
13.69x1.34x8.17x6.16% 19.64B
23.23x2.07x9.97x1.57% 7.88B
63.82x - - - 2.25B
14.53x1.15x7.77x2.71% 1.46B
9.71x1.52x7.98x3.61% 1.41B
10.33x - - - 1.4B
29.34x - - - 1.19B
Average 23.52x 1.52x 8.47x 3.51% 4.42B
Weighted average by Cap. 19.30x 1.53x 8.61x 4.68%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. AAA Stock
  4. Valuation An Phat Bioplastics